Receptors, genetics and malignant hyperpyrexia
Shapira, Y.; Gurman, G.M.
Harefuah 132(12): 849-850
1997
ISSN/ISBN: 0017-7768 PMID: 9264191 Document Number: 480418
Document emailed within 1 workday
Related Documents
Huska, L.; Little, H.; Doust, J.W. 1970: A case of malignant hyperpyrexia Canadian Medical Association Journal 103(9): 961-962Kito, S. 1978: Malignant hyperpyrexia and muscular lesions Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl: 1752-1753
Sutherland, F.S.; Carter, J.R. 1975: Malignant hyperpyrexia during enflurane anesthesia Journal of the Tennessee Medical Association 68(10): 795-796
Matossi L'Orsa, R.; Miegge, C.; Bona, C.; Debernardi, F.; Carmignani, F.; Bagliani, C.; Giustetto, A. 1978: Malignant hyperpyrexia. Etiopathogenetic and therapeutic considerations Minerva Anestesiologica 44(6): 377-390
Staunton, M.; Hughes, N. 1997: Thyrotoxicosis in multiple trauma. Malignant hyperpyrexia should have been considered Bmj 314(7082): 752-753
Ward, R.J.; Eisele, J.W.; Reay, D.T.; Horton, W.G. 1986: Hemolysis and hyperkalemia complicate malignant hyperpyrexia during anesthetic death Journal of Forensic Sciences 31(2): 543-545
Isaacs, H.; Heffron, J.J.; Badenhorst, M. 1975: 'Picture frame' fibres in a carrier of the trait for malignant hyperpyrexia South African Medical Journal 49(46): 1923-1926
Berman, M.C.; Harrison, G.G.; Bull, A.B.; Kench, J.E. 1970: Changes underlying halothane-induced malignant hyperpyrexia in Landrace pigs Nature 225(5233): 653-655
Cain, P.A.; Ellis, F.R. 1977: Anaesthesia for patients susceptible to malignant hyperpyrexia. A study of pancuronium and methylprednisolone British Journal of Anaesthesia 49(9): 941-944
Halsall, P.J.; Cain, P.A.; Ellis, F.R. 1979: Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized British Journal of Anaesthesia 51(10): 949-954
Zigmund, M.; Nikuseva-Martić, T.; Cacić, M.; Pećina-Slaus, N. 2005: New insights on genetics of malignant melanoma Lijecnicki Vjesnik 127(3-4): 89-93
Lazarević, M. 1983: Genetics of malignant tumors. Current problems and perspectives Srpski Arhiv Za Celokupno Lekarstvo 111(1): 67-78
Soler, J. 1992: Molecular genetics and malignant hemopathies. the current situation Medicina Clinica 98(3): 94-95
McCarthy, T.V.; Healy, J.M.; Lehane, M.; Heffron, J.J. 1990: Recent developments in the molecular genetics of malignant hyperthermia: implications for future diagnosis at the DNA level Acta Anaesthesiologica Belgica 41(2): 107-112
Harrington, D.S.; Patil, K.; Lai, P.K.; Yasuda, N.N.; Armitage, J.O.; Ip, S.H.; Weisenburger, D.D.; Linder, J.; Purtilo, D.T. 1988: Soluble interleukin 2 receptors in patients with malignant lymphoma Archives of Pathology and Laboratory Medicine 112(6): 597-601
D'Onofrio, M.; de Grazia, U.; Morrone, S.; Cuomo, L.; Spinsanti, P.; Frati, L.; Gulino, A.; Ragona, G. 2000: Expression of neurotrophin receptors in normal and malignant B lymphocytes European Cytokine Network 11(2): 283-291
Brychtova, S.; Bezdekova, M.; Brychta, T.; Tichy, M. 2008: The role of vascular endothelial growth factors and their receptors in malignant melanomas Neoplasma 55(4): 273-279
Ji, Y.Y. 1989: Localization of ricinus agglutinin receptors in tumor cells in malignant histiocytosis Zhonghua Yi Xue Za Zhi 69(3): 166-168
Weir, B.S. 1987: Anecdotal, historical and critical commentaries on genetics quantitative genetics in 1987 Genetics 117(4): 601-602
Gomes, W.J.; Weerasuriya, N. 1975: Hyperpyrexia in neonates: a sign of intraventricular haemorrhage Indian Pediatrics 12(6): 505-507